Index - P/E - EPS (ttm) -18.26 Insider Own 1.26% Shs Outstand 46.00M Perf Week 10.76%
Market Cap 2.68B Forward P/E 12.33 EPS next Y 4.75 Insider Trans 0.00% Shs Float 45.14M Perf Month 15.47%
Enterprise Value 3.90B PEG - EPS next Q 0.24 Inst Own 98.64% Short Float 7.62% Perf Quarter 7.35%
Income -843.00M P/S 1.47 EPS this Y 17.60% Inst Trans -3.31% Short Ratio 4.36 Perf Half Y 16.88%
Sales 1.82B P/B 1.42 EPS next Y 19.50% ROA -16.03% Short Interest 3.44M Perf YTD -18.01%
Book/sh 41.39 P/C 10.11 EPS next 5Y 17.56% ROE -34.45% 52W High 78.11 -25.00% Perf Year -25.55%
Cash/sh 5.80 P/FCF 74.41 EPS past 3/5Y -95.12% -15.51% ROIC -24.99% 52W Low 45.21 29.60% Perf 3Y -47.63%
Dividend Est. 1.51 (2.58%) EV/EBITDA 10.17 Sales past 3/5Y -8.63% -1.98% Gross Margin 23.95% Volatility 3.91% 3.39% Perf 5Y -22.06%
Dividend TTM 2.05 (3.51%) EV/Sales 2.14 EPS Y/Y TTM -608.89% Oper. Margin 5.32% ATR (14) 1.80 Perf 10Y 6.55%
Dividend Ex-Date Dec 01, 2025 Quick Ratio 1.51 Sales Y/Y TTM -13.67% Profit Margin -46.19% RSI (14) 72.03 Recom 1.92
Dividend Gr. 3/5Y 8.90% 8.32% Current Ratio 2.85 EPS Q/Q 113.05% SMA20 11.60% Beta 0.42 Target Price 62.28
Payout 46.75% Debt/Eq 0.78 Sales Q/Q -8.43% SMA50 16.23% Rel Volume 1.18 Prev Close 58.29
Employees 2900 LT Debt/Eq 0.77 Earnings Nov 04 AMC SMA200 11.79% Avg Volume 788.43K Price 58.59
IPO May 08, 1950 Option/Short Yes / Yes EPS/Sales Surpr. -13.12% -0.89% Trades
Volume 927,602 Change 0.51%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-08-25 Initiated Morgan Stanley
Equal-Weight
$60
May-01-25 Downgrade Wells Fargo
Overweight → Equal Weight
Mar-26-25 Upgrade JP Morgan
Neutral → Overweight
$68 → $71
Mar-05-25 Downgrade Seaport Research Partners
Buy → Neutral
Aug-08-24 Upgrade JP Morgan
Underweight → Neutral
$90 → $89
Apr-11-24 Upgrade Wells Fargo
Equal Weight → Overweight
$100 → $112
Mar-14-24 Upgrade Jefferies
Hold → Buy
$100 → $126
Mar-01-24 Initiated Wolfe Research
Outperform
$108
Jun-29-23 Downgrade Evercore ISI
Outperform → In-line
Jun-26-23 Downgrade BMO Capital Markets
Outperform → Market Perform
$109 → $90
Feb-02-23 Downgrade JP Morgan
Neutral → Underweight
$104 → $105
Sep-12-22 Initiated Credit Suisse
Outperform
$120
Jan-20-22 Downgrade Wells Fargo
Overweight → Equal Weight
$120 → $110
Nov-11-21 Downgrade Monness Crespi & Hardt
Buy → Neutral
Oct-13-21 Initiated Mizuho
Buy
$116
Jul-30-21 Upgrade JP Morgan
Underweight → Neutral
$90
Jun-18-21 Initiated Stifel
Buy
$118
May-04-21 Downgrade JP Morgan
Neutral → Underweight
$88 → $89
Mar-15-21 Resumed Credit Suisse
Outperform
$103
Feb-05-21 Reiterated Monness Crespi & Hardt
Buy
$88 → $100
Show Previous Ratings
Dec-05-25 06:35PM
Dec-04-25 11:30AM
Dec-03-25 12:27PM
Dec-01-25 04:34PM
Nov-19-25 05:01PM
07:12AM
Loading…
Nov-06-25 07:12AM
Nov-05-25 04:05PM
Nov-04-25 07:30PM
06:35PM
05:46PM
(Associated Press Finance)
05:01PM
07:49AM
Nov-03-25 07:34AM
Oct-30-25 05:01PM
Oct-28-25 10:00AM
07:00AM
Loading…
Oct-23-25 07:00AM
Oct-14-25 05:01PM
Sep-30-25 05:01PM
Sep-12-25 08:19AM
06:10AM
Aug-28-25 11:30AM
Aug-12-25 05:30PM
08:56AM
Aug-08-25 05:01PM
Aug-05-25 08:18AM
Jul-31-25 03:25AM
Jul-29-25 07:00PM
06:15PM
05:11PM
(Associated Press Finance)
05:01PM
09:41AM
Loading…
09:41AM
Jul-28-25 09:27AM
Jul-23-25 10:00AM
Jul-22-25 10:00AM
Jul-21-25 05:00PM
Jul-16-25 05:00PM
Jul-14-25 05:00PM
Jul-09-25 09:29AM
Jul-08-25 05:00PM
Jun-05-25 09:05AM
May-30-25 11:31AM
May-28-25 05:00PM
May-14-25 01:37PM
May-08-25 06:45AM
May-06-25 05:15PM
08:49AM
May-05-25 05:00PM
May-02-25 03:12AM
02:54AM
(Thomson Reuters StreetEvents)
May-01-25 07:48PM
Apr-30-25 07:30PM
06:50PM
05:47PM
(Associated Press Finance)
05:01PM
Apr-24-25 10:01AM
08:15AM
Apr-23-25 10:01AM
Apr-22-25 11:02AM
Apr-17-25 11:16PM
06:30AM
Apr-11-25 10:07AM
Apr-10-25 09:02AM
05:50AM
Apr-03-25 12:04PM
Apr-01-25 06:59AM
Mar-28-25 05:03PM
06:59AM
Mar-26-25 10:21PM
Mar-17-25 07:00AM
Mar-13-25 02:41PM
Feb-22-25 10:04AM
Feb-13-25 08:14AM
Jan-31-25 02:17AM
Jan-30-25 03:10AM
(Thomson Reuters StreetEvents)
Jan-28-25 05:23PM
(Associated Press Finance)
-9.82%
05:01PM
07:08AM
Jan-27-25 07:04AM
Jan-20-25 05:00PM
01:09PM
Jan-16-25 07:09AM
Jan-14-25 07:00AM
Dec-23-24 05:01PM
Dec-16-24 04:15PM
Dec-09-24 05:01PM
06:30AM
Nov-21-24 01:00AM
Nov-14-24 07:00AM
Nov-08-24 07:00AM
02:16AM
Nov-06-24 07:15PM
06:27PM
(Associated Press Finance)
05:00PM
07:09AM
Nov-05-24 09:15AM
07:40AM
Oct-31-24 12:22PM
Oct-28-24 05:00PM
Oct-09-24 10:40AM
Oct-07-24 07:31AM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NOVO GUILLERMO Chair of the Board and CEO Nov 17 '25 Option Exercise 49.60 6,122 303,651 143,412 Nov 19 04:30 PM Drury Eileen SVP and Chief HRO Nov 17 '25 Option Exercise 49.60 567 28,123 7,881 Nov 19 04:30 PM MUSA OSAMA M SVP and CTO Nov 17 '25 Option Exercise 49.60 976 48,410 29,875 Nov 19 04:30 PM MUSA OSAMA M SVP and CTO Nov 14 '25 Option Exercise 51.51 2,091 107,707 29,616 Nov 19 04:30 PM MUSA OSAMA M SVP and CTO Nov 13 '25 Option Exercise 53.10 1,393 73,968 28,002 Nov 19 04:30 PM RICHARDSON SAMUEL VP, Controller and PAO Nov 17 '25 Option Exercise 49.60 107 5,307 1,104 Nov 19 04:30 PM WHITAKER WILLIAM SVP, CFO & PFO Nov 17 '25 Option Exercise 49.60 107 5,307 2,082 Nov 19 04:30 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 17 '25 Option Exercise 49.60 239 11,854 5,095 Nov 19 04:30 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 14 '25 Option Exercise 51.51 1,276 65,727 5,237 Nov 17 09:43 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 13 '25 Option Exercise 53.10 866 45,985 4,220 Nov 17 09:43 PM NOVO GUILLERMO Chair of the Board and CEO Nov 13 '25 Option Exercise 53.10 9,029 479,440 135,767 Nov 17 09:43 PM NOVO GUILLERMO Chair of the Board and CEO Nov 14 '25 Option Exercise 51.51 9,119 469,720 141,107 Nov 17 09:43 PM Drury Eileen SVP and Chief HRO Nov 14 '25 Option Exercise 51.51 1,297 66,808 7,917 Nov 17 09:38 PM Drury Eileen SVP and Chief HRO Nov 13 '25 Option Exercise 53.10 863 45,825 7,020 Nov 17 09:38 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 14 '25 Option Exercise 51.51 1,225 63,100 4,640 Nov 17 09:38 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 13 '25 Option Exercise 53.10 1,020 54,162 3,734 Nov 17 09:38 PM Assis Alessandra Faccin SVP and GM, Life Sciences Nov 13 '25 Option Exercise 53.10 1,340 71,154 6,286 Nov 17 09:37 PM Caceres Dago SVP & GM, Specialty Additives Nov 13 '25 Option Exercise 53.10 746 39,613 746 Nov 17 09:37 PM WHITAKER WILLIAM SVP, CFO & PFO Nov 14 '25 Option Exercise 51.51 356 18,338 2,083 Nov 17 09:36 PM WHITAKER WILLIAM SVP, CFO & PFO Nov 13 '25 Option Exercise 53.10 229 12,160 1,797 Nov 17 09:36 PM RICHARDSON SAMUEL VP, Controller and PAO Nov 14 '25 Option Exercise 51.51 228 11,744 1,066 Nov 17 09:35 PM RICHARDSON SAMUEL VP, Controller and PAO Nov 13 '25 Option Exercise 53.10 146 7,753 882 Nov 17 09:35 PM Assis Alessandra Faccin SVP and GM, Life Sciences Jul 25 '25 Option Exercise 51.26 3,123 160,085 6,273 Jul 28 04:30 PM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '25 Option Exercise 49.99 1,395 69,736 3,149 May 12 04:30 PM Kulkarni Ashish K Director May 06 '25 Option Exercise 0.00 1,032 0 1,032 May 08 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Jan 31 '25 Buy 64.24 31,294 2,010,327 31,294 Feb 03 04:30 PM Assis Alessandra Faccin SVP and GM, Life Sciences Jan 31 '25 Buy 64.00 3,150 201,600 3,150 Feb 03 04:30 PM Harrison Suzan F. Director Jan 23 '25 Option Exercise 0.00 1,931 0 1,931 Jan 24 04:30 PM
